Abstract
The high incidence of remission and prevention of relapse of minimal change nephrotic syndrome (MCNS) in children, produced by corticosteroids is reviewed. With the introduction of corticosteroids over 30 years ago and the increased expertise in their use, the mortality rate has been reduced to less than 5%. There is no justification for a clinical trial to test the effect of corticosteroids in inducing remission, but the need remains to evaluate methods of administration in order to achieve therapeutic benefit with minimum toxicity. children with frequently relapsing, steroid-dependent MCNS will usually enter remission following treatment with an alkylating agent such as cyclophosphamide. In about 50% no further relapse in experienced. The results of recent experience using cyclosporin A immunosuppression suggest a beneficial effect associated with steroid responsiveness. Approximately 30% of children with focal segmental glomerulosclerosis enter remission following treatment with corticosteroids. Some 30% require dialysis and transplantation within 5 years of diagnosis and immunosuppressive therapy to prevent deterioration of renal function is probably justified.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Churg J, Habib R, White RHR (1970) Pathology of the nephrotic syndrome in children. A report for the International Study of Kidney Disease in Children. Lancet I: 1299–1302
White RHR, Glasgow EF, Mills RJ (1970) Clinico-pathological study of nephrotic syndrome in childhood. Lancet 1:1353–1359
Barnett HL, McNamara H, McCrory W, Forman C, Rapoport M, Michie A, Barbero G (1950) Effect of ACTH and cortisone on the nephrotic syndrome. Am J Dis Child 80:519–520
Black DAK, Rose G, Brewer DB (1970) Controlled trial of prednisolone in adult patients in the nephrotic syndrome. Br Med J 3:4221–4226
Tanner JM, Whitehouse RH, Takaishi M (1981) Standards from birth to maturity for height, weight, height velocity and weight velocity: British children, 1965. Part I. J Pediatr 98:561–564
Report of the International Study of Kidney Disease in Children. (1981) The primary nephrotic syndrome in children. Identification of patients and minimal change nephrotic syndrome form initial response to prednisone. J Pediatr 98:561–564
Barnett HL, Schoeneman M, Bernstein J, Edelmann CM (1978) Minimal change nephrotic syndrome. In: Edelmann CM (ed) Pediatric Kidney Disease. Little Brown, Boston, pp 695–711
Report of the International Study of Kidney Disease in Children (1982) Early identification of frequent relapses among children with minimal change nephrotic syndrome. J Pediatr 101:514–518
Leisti S, Hallman N, Koskimes O, Perheentupa J, Rapola J, Vilska J (1977) Association of post-medication hypocortisolism with early first relapse of idiopathic nephrotic syndrome. Lancet II:795–796
Report of the International Study of Kidney Disease in Children (1979) Nephrotic syndrome in children: a randomized trial comparing two prednisone regimes in steroid responsive patients with relapse early. J Pediatr 95: 239–243
Ponticelli C, Imbasciati E, Case N, Zucchelli P, Cagnoli, L, Pasquali S (1980) Intravenous methyl prednisolone in minimal change nephrotic syndrome. Br Med J 280:285
Kennedy TL, Rasoulpour M, McLean RH (1980) Intravenous methyl prednisolone in the treatment of steroid responsive nephrotic syndrome. Pediatr Res 14:1006
Yeung CH, Wong KL, Ng WL (1983) Intravenous methyl prednisolone pulse therapy in minimal change nephrotic syndrome. Aust NZJ Med 13:349–351
Schoeneman MJ (1983) Minimal change nephrotic syndrome: treatment with low doses of hydrocortisone. J Pediatr 102:791–793
Arbeitsgemeinschaft für Paediatrische Nephrologie (1970) Alternate day versus intermittent prednisone in frequently relapsing nephrotic syndrome. Lancet I:401–403
Coldbeck JH (1963) Experience with alkylating agents in the treatment of children with the nephrotic syndrome. Med J Aust 2:987–989
Chiu J, McLain PN, Drummond KN (1973) A controlled prospective study of cyclophosphamide in relapsing, corticosteroid responsive, minimal-lesion nephrotic syndrome in childhood. J Pediatr 82:607–613
Report of the International Study of Kidney Disease in Children (1974) Prospective controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Lancet II:423–427
Barratt TM, Bercowscy A, Osofsky SG, Soothill JF, Kay R (1975) Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome. Lancet I:55–58
Barratt TM, Cameron JS, Chantler C, Ogg CS Soothill JF (1973) A comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome in childhood. Arch Dis Child 48:286–290
Cameron JS, Chantler C, Ogg CS, White RHR (1974) Long-term stability in nephrotic syndrome after treatment with cyclophosphamide. Br Med J 4:7–11
McDonald J, Murphy AV, Arneil GC (1974) Long-term assessment of cyclophosphamide therapy of nephrosis in children. Lancet II:980–982
Arbeitsgemeinschaft für Paediatrische Nephrologie (1987) Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of 8 week and 12 week course. Arch Dis Child 62:1102–1106
Garin EH, Pryor ND, Fennell RS, Richard GA (1978) Pattern of response to prednisone in idiopathic minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy. J Pediatr 92: 304–308
Arbeitsgemeinschaft für Paediatrische Nephrologie (1982) Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. N Engl J Med 306:451–454
Barratt TM, Soothill JF (1970) Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet II:479–482
Grupe WE, Makker SP, Ingelfinger JR (1976) Chlorambucil treatment of frequently relapsing nephrotic syndrome. N Engl J Med 295:746–749
West CD (1958) The use of combined and mechlorethamine (nitrogen mustard) therapy in lipoid nephrosis. Am J Dis Child 95:498–515
Schoeneman MJU, Spitzer A, Griefer I (1983) Nitrogen mustard therapy in children with frequent-relapsing nephrotic syndrome and steroid toxicity. Am J Kidney Dis 5:526–529
Abramowitz M, Barnett HL, Edelman CM, Greifer I, Kobayashi O, Arneil GC, Barton BA, Gordillo G, Hallman N, Tiddens HA (1970) Controlled trial of azathioprine in children with nephrotic syndrome. A report for the International Study of Kidney Disease in Children. Lancet I: 959–961
Barratt TM, Cameron JS, Chantler C, Counahan R, Ogg CS, Soothill JF (1977) Controlled trial of azathioprine in treatment of steroid-responsive nephrotic syndrome of childhood. Arch Dis Child 52:462–464
Tanphaichitr P, Tanpaaichitr D, Sureeratanan J, Chatasingh S (1980) Treatment of nephrotic syndrome with levamisole. J Pediatr 96:490–493
Niaudet I, Beaurais G, Clement A, Broyer M (1984) Levamisole therapy in steroid dependent nephrotic syndrome in childhood. Acta Paediatr Scand 73:637–641
Mehta KP, Ali U, Kutty M, Kolhatkar U (1986) Immunoregulatory treatment for minimal change nephrotic syndrome. Arch Dis Child 61:153–158
Meyrier A, Simon P, Gerard P, Condamin-Meyrier MC (1986) Remission of idiopathic nephrotic syndrome after treatment with Cyclosporin A. Br Med J 292:789
Brodehl J, Hoyer PF (1985) Cyclosporin treatment of idiopathic nephrotic syndrome in children (minimal change disease and focal segmental glomerulosclerosis) In: Schindler R (ed) Cyclosporin in autoimmune diseases. 1st International Symposium. Springer, Berlin Heidelberg New York, p 329.
Capodicasa G, De Sando NG, Nuzzi F, Giordano C (1986) Cyclosporin A in nephrotic syndrome of childhood — a 14 month experience. Int J Pediatr Nephrol 7:69–72
Niaudet P, Habib R, Tete MJ, Hinglais N, Broyer M (1987) Cyclosporin in the treatment of idiopathic nephrotic syndrome in children. Pediatr Nephrol 1:566–573
Tejani A, Butt Khalid Trachtman H, Susanthiran M, Rosenthal CJ, Khawar MR (1988) Cyclosporin A induced remission of relapsing nephrotic syndrome in children. Kidney Int 33:729–734
Hayslett JP, Krasser LS, Bensch KG, Kashgarian M, Epstein FH (1976) Progression of “lipoid nephrosis” to renal insufficiency. N Engl J Med 281:181–187
Cameron JS (1978) The problem of focal segmental glomerulosclerosis. In: Kincaid-Smith P, D'Apice AF, Atkings RE (eds) Recent progress. Wiley, New York, pp 212–228
Trompeter RS, Barratt TM (1988) Treatment and management of nephrotic syndrome in children. In: Cameron JS, Glassock RJ (eds) The nephrotic syndrome. Dekker, New York, p 441
Newman WJ, Tisher CC, McCoy RC, Gunnells JC, Krueger RP, Clapp JR, Robinson RR (1946) Focal glomerular sclerosis: contrasting clinical patterns in children and adults. Medicine (Baltimore) 55:67–87
Gubler MC, Waldherr R, Levy M, Broyer M, Babib R (1979) Idiopathic nephrotic syndrome with focal and segmental sclerosis and/or hyalinosis: clinical course, response to therapy and long-term outcome. In: Strauss J (ed) Pediatric nephrology. STPM Press, Garland, 193–212
International Study of Kidney Disease in Children (1980) Proceedings of the 5th International Paediatric Nephrology Symposium 1980. Pediatr Res 14:1006
Mongeau JG, Corneille L, Robitaille P, O'Regan S, Pelletier M (1981) Primary nephrosis in childhood associated with focal glomerular sclerosis: is long term prognosis that severe? Kidney Int 20:743–746
Adhikari M (1985) Cyclosporin in steroid insensitive nephrotic syndrome in Durban, South Africa. In: Schindler R (ed) Cyclosporin in autoimmune diseases 1st International Symposium. Springer, Berlin Heidelberg New York, p 323
Futrakul P, Poshyachinda M, Mitrakul C (1978) Focal sclerosing glomerulonephritis. A kinetic evaluation of hemostasis and the effect of anticoagulation therapy: a controlled study. Clin Nephrol 10:180–186
Donker AJM, Brentjens GK, V de Hem GK, Ariz L (1978) Treatment of the nephrotic syndrome with indomethacin. Nephron 22:374–381
Shehedah FH, Demers LM, Abt AB, Schoolworth AC (1979) Indomethacin and the nephrotic syndrome. JAMA 241:1264–1266
Rees L, Greene SA, Adlard P, Jones J, Haycock GB, Rigden SPA, Preece M, Chantler C (1988) Growth and endocrine function in steroid sensitive nephrotic syndrome. Arch Dis Child 63:484–490
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Trompeter, R.S. Immunosuppressive therapy in the nephrotic syndrome in children. Pediatr Nephrol 3, 194–200 (1989). https://doi.org/10.1007/BF00852910
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00852910